Avanos Medical Inc (NYSE: AVNS) is -3.27% lower on its value in year-to-date trading and has touched a low of $15.37 and a high of $25.36 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The AVNS stock was last observed hovering at around $15.46 in the last trading session, with the day’s loss setting it -0.06%.
Currently trading at $15.40, the stock is -6.91% and -15.54% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.23 million and changing -0.39% at the moment leaves the stock -25.12% off its SMA200. AVNS registered -18.99% loss for a year compared to 6-month loss of -20.58%. The firm has a 50-day simple moving average (SMA 50) of $18.3718 and a 200-day simple moving average (SMA200) of $20.5859.
The stock witnessed a -16.62% gain in the last 1 month and extending the period to 3 months gives it a -31.22%, and is -3.27% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.17% over the week and 3.17% over the month.
Avanos Medical Inc (AVNS) has around 3771 employees, a market worth around $707.74M and $681.50M in sales. Current P/E ratio is 45.66 and Fwd P/E is 9.06. Profit margin for the company is 2.30%. Distance from 52-week low is 0.18% and -39.27% from its 52-week high. The company has generated returns on investments over the last 12 months (1.11%).
The EPS is expected to grow by 28.64% this year
361.0 institutions hold shares in Avanos Medical Inc (AVNS), with institutional investors hold 98.97% of the company’s shares. The shares outstanding are 45.95M, and float is at 44.88M with Short Float at 1.62%. Institutions hold 96.10% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 7.01 million shares valued at $139.66 million. The investor’s holdings represent 15.1758 of the AVNS Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 5.27 million shares valued at $104.98 million to account for 11.4072 of the shares outstanding. The other top investors are RGM CAPITAL, LLC which holds 3.17 million shares representing 6.8646 and valued at over $63.18 million, while DIMENSIONAL FUND ADVISORS LP holds 5.5793 of the shares totaling 2.58 million with a market value of $51.35 million.
Avanos Medical Inc (AVNS) Insider Activity
The most recent transaction is an insider sale by Greiner Michael, the company’s SVP – Chief Financial Officer. SEC filings show that Greiner Michael sold 8,000 shares of the company’s common stock on Mar 14 ’24 at a price of $19.12 per share for a total of $0.15 million. Following the sale, the insider now owns 0.15 million shares.
Avanos Medical Inc disclosed in a document filed with the SEC on Mar 11 ’24 that Shimer Julie Ann (Director) bought a total of 500 shares of the company’s common stock. The trade occurred on Mar 11 ’24 and was made at $19.85 per share for $9925.0. Following the transaction, the insider now directly holds 50090.0 shares of the AVNS stock.
